Bergeson & Campbell, P.C. Quoted in Inside EPA Article “New EPA Guide Aims To Improve Synthetic Biology Algae Project Reviews”
A September 3, 2015, Inside EPA article regarding EPA’s efforts to improve how it reviews companies’ proposals to develop synthetic biology products, and specifically biotech algae, featured quotes from Bergeson & Campbell, P.C.:
In a recent memo to clients, the law firm Bergeson & Campbell calls the announcement of the algae guide update “hugely important for the industrial biotechnology communities,” adding that “EPA’s announcement suggests a broader Agency initiative is underway, and is best read in the context of other relevant developments.”
As an example, the firm points to a July 2 White House Office of Science and Technology Policy memo to EPA, the Food and Drug Administration and the Department of Agriculture, directing the agencies to update the Coordinated Framework for the Regulation of Biotechnology.
“The memorandum reflects the Administration’s acknowledgment that the Framework needs to be updated to reflect the tremendous explosion of new technologies addressed by the federal family or regulatory agencies and the lack, in some instances, of a coherent regulatory framework that innovators and others can anticipate and follow in commercializing their products,” the law firm’s memo says.